Cargando…

Stable core virome despite variable microbiome after fecal transfer

We recently described the 4.5-year time course of the enteric bacterial microbiota and virome of a patient cured from recurrent Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT). Here, we extended the virome analyses and found the patient's phage population to exh...

Descripción completa

Detalles Bibliográficos
Autores principales: Broecker, Felix, Russo, Giancarlo, Klumpp, Jochen, Moelling, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479397/
https://www.ncbi.nlm.nih.gov/pubmed/27935413
http://dx.doi.org/10.1080/19490976.2016.1265196
_version_ 1783245125811437568
author Broecker, Felix
Russo, Giancarlo
Klumpp, Jochen
Moelling, Karin
author_facet Broecker, Felix
Russo, Giancarlo
Klumpp, Jochen
Moelling, Karin
author_sort Broecker, Felix
collection PubMed
description We recently described the 4.5-year time course of the enteric bacterial microbiota and virome of a patient cured from recurrent Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT). Here, we extended the virome analyses and found the patient's phage population to exhibit highly donor-similar characteristics following FMT, which remained stable for the whole period tested (up to 7 months). Moreover, the detected viral populations of donor and patient exhibited comparable diversity and richness. These findings were unexpected since enteric viromes are normally highly variable, assumed to influence the bacterial host community and change with environmental conditions. In contrast to the virome, the bacterial microbiota varied indeed for more than 7 months with ongoing dysbiosis before it reached donor similarity. Our findings that are based on sequence information and protein domain analysis seem to suggest that stable phage properties correlate with successful FMT better than the changing bacterial communities. We speculate that we here preferentially detected a stable core virome, which dominated over a variable flexible virome that may have been too heterogeneous for experimental detection or was underrepresented in the databases. It will be interesting to analyze whether the enteric virome allows predictions for the clinical outcome of FMT for rCDI and other diseases such as inflammatory bowel disease or obesity.
format Online
Article
Text
id pubmed-5479397
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-54793972017-06-27 Stable core virome despite variable microbiome after fecal transfer Broecker, Felix Russo, Giancarlo Klumpp, Jochen Moelling, Karin Gut Microbes Review We recently described the 4.5-year time course of the enteric bacterial microbiota and virome of a patient cured from recurrent Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT). Here, we extended the virome analyses and found the patient's phage population to exhibit highly donor-similar characteristics following FMT, which remained stable for the whole period tested (up to 7 months). Moreover, the detected viral populations of donor and patient exhibited comparable diversity and richness. These findings were unexpected since enteric viromes are normally highly variable, assumed to influence the bacterial host community and change with environmental conditions. In contrast to the virome, the bacterial microbiota varied indeed for more than 7 months with ongoing dysbiosis before it reached donor similarity. Our findings that are based on sequence information and protein domain analysis seem to suggest that stable phage properties correlate with successful FMT better than the changing bacterial communities. We speculate that we here preferentially detected a stable core virome, which dominated over a variable flexible virome that may have been too heterogeneous for experimental detection or was underrepresented in the databases. It will be interesting to analyze whether the enteric virome allows predictions for the clinical outcome of FMT for rCDI and other diseases such as inflammatory bowel disease or obesity. Taylor & Francis 2016-12-09 /pmc/articles/PMC5479397/ /pubmed/27935413 http://dx.doi.org/10.1080/19490976.2016.1265196 Text en © 2017 The Author(s). Published with license by Taylor & Francis http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Review
Broecker, Felix
Russo, Giancarlo
Klumpp, Jochen
Moelling, Karin
Stable core virome despite variable microbiome after fecal transfer
title Stable core virome despite variable microbiome after fecal transfer
title_full Stable core virome despite variable microbiome after fecal transfer
title_fullStr Stable core virome despite variable microbiome after fecal transfer
title_full_unstemmed Stable core virome despite variable microbiome after fecal transfer
title_short Stable core virome despite variable microbiome after fecal transfer
title_sort stable core virome despite variable microbiome after fecal transfer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479397/
https://www.ncbi.nlm.nih.gov/pubmed/27935413
http://dx.doi.org/10.1080/19490976.2016.1265196
work_keys_str_mv AT broeckerfelix stablecoreviromedespitevariablemicrobiomeafterfecaltransfer
AT russogiancarlo stablecoreviromedespitevariablemicrobiomeafterfecaltransfer
AT klumppjochen stablecoreviromedespitevariablemicrobiomeafterfecaltransfer
AT moellingkarin stablecoreviromedespitevariablemicrobiomeafterfecaltransfer